Shrinkage patterns correlate strongly with tumor biology: concentric shrinkage is associated with HER2-positive tumors and higher pCR rates [48,49], whereas mixed or irregular shrinkage are common in Luminal A tumors, which have lower chemosensitivity [50]. Here, ERBB2 is linked to neoplasm.